Bidichandani presented data from a prospective study of 48 people with FA; testing freshly isolated peripheral blood mononuclear cells for response to HDAC inhibitor treatment and how this corresponded to levels of FXN CGI shore methylation. The gene discussed is FXN; the disease is Friedreich ataxia.